+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-invasive Aesthetic Treatment Market Report by Procedure, Injectables, Skin Rejuvenation, Others, Gender, End User, Country and Company Analysis 2024-2032

  • PDF Icon

    Report

  • 190 Pages
  • June 2024
  • Region: Global
  • Renub Research
  • ID: 5696928
Non-Invasive Aesthetic Treatment market will reach US$ 220.84 billion by 2032 from US$ 65.65 Billion in 2023, with a CAGR of 14.3 percent from 2024 to 2032.

A non-invasive approach is a form of treatment that doesn't require surgical procedure or the removal of tissues. In today's cutting-edge generation, many people are concerned about the signs and symptoms of growing older, such as age spots, sagging skin, and wrinkles across the mouth or eyes. There are numerous non-invasive beauty approaches to be had to reduce these outcomes. Everyday non-invasive cosmetic products include peels, hyaluronic acid, and botulinum toxin. Today, patients regularly choose over-the-counter cosmetics rather than topical ones because of lower cost, shorter recovery instances, no scarring, and a reduced chance of side effects.

The multiplied use of social media has made humans bodily appearances more critical in social and professional settings. Video calls have emerged as a common way for human beings to have interaction, increasing the emphasis on projecting their best selves visually. Additionally, the media and popular life's focus on look, as seen through celebrities, movies, and fashion ads, has raised splendor standards. This has led many humans, specifically millennials and Generation Z, to look for non-surgical methods to improve their appearance and achieve their preferred appearance.

According to the International Society of Aesthetic Plastic Surgery, 18,857,311 non-surgical aesthetic approaches had been executed globally in 2022. Botulinum toxin emerged as the most popular non-surgical procedure in 2022, with 9,221,419 international methods. Hyaluronic acid ranked as the second most sought-after non-surgical operation in 2022, with 4,312,037 processes executed globally. In 2022, 642,067 non-surgical fat reduction approaches were carried out worldwide for women, and 136,650 approaches were completed for men. Additionally, 916,869 hair elimination techniques were carried out in 2018 and 1,798,253 in 2022, indicating a 96.1% increase between 2018 and 2022.

Recent technological improvements have greatly improved non-invasive aesthetic approaches, making them more powerful and handy to individuals trying to enhance their look without invasive surgical methods. This trend is anticipated to force the boom of the non-invasive aesthetic treatment marketplace. The advent of strength-based, totally non-invasive gadgets that utilize radiofrequency, ultrasound, mild, and laser to target fats and muscle is revolutionizing the industry. These innovative technologies allow patients to get hold of remedies without surgical operation or anesthesia, decreasing dangers and accelerating healing.
  • In August 2020, Lumenis Ltd added a completely unique non-invasive treatment referred to as NuEra Tight with FocalRF era.
  • Alma Lasers added the Harmony XL Pro in 2020, which gives diverse non-invasive beauty remedies inclusive of pimples treatment, hair elimination, and pores and skin rejuvenation the usage of advanced IPL generation.

North America Non-Invasive Aesthetic Treatment Market:

North America had the largest market percentage for non-invasive aesthetic remedies in sales. This place is anticipated to dominate inside the forecast duration because of stepped forward facilities, improved demand for non-invasive aesthetic remedies, and a growing senior populace. Additionally, superior medical devices and well-mounted healthcare infrastructure are important elements riding the growth of North America's non-invasive aesthetic remedy marketplace. For instance, from 2000 to 2018, there was an 845% boom in the use of Botox injections inside the US, as stated through the American Society of Plastic Surgeons. Factors contributing to this marketplace dominance consist of high disposable income, a rapidly getting older populace, and a multiplied awareness on aesthetic look.

Furthermore, the presence of many professional plastic surgeons and the better adoption of superior treatments also are sizable members. As of 2019, there had been round 7,000 plastic surgeons within the US, in step with the International Society of Aesthetic Plastic Surgery. These factors combined have led to the North American area's dominance within the worldwide non-invasive aesthetic remedy market.

Asia Pacific Non-Invasive Aesthetic Treatment Market

Asia-Pacific region is anticipated to enjoy great increase due to growing disposable income and improving living requirements, leading to higher consumer spending on non-invasive aesthetic methods. Additionally, a growing consciousness of non-invasive remedies and a choice for Western beauty standards pressure the demand for these tactics in the vicinity. According to the United Nations, around 80% of the worldwide old age populace will stay in low- and middle-profits countries by means of 2050. Therefore, the Asia Pacific area gives profitable boom opportunities to marketplace gamers. Furthermore, the development within the gender ratio is anticipated to foster the adoption of aesthetic remedies among ladies inside the Asia Pacific. The rising awareness of consumers towards aesthetic appearances is fueling the increase of the Asia Pacific non-invasive aesthetic remedy marketplace.

Non-Invasive Aesthetic Treatment Company Analysis

Major global breast implant industry companies include Johnson & Johnson, Bausch Health Companies Inc., Cutera Inc., AbbVie Inc., Sisram Medical Ltd, Galderma S.A., Sientra Inc., and Revance Therapeutics Inc.

Non-Invasive Aesthetic Treatment Market Company News:

Feb 2024: AMP has launched Plasmage, the first fractional plasma device. This device offers clinicians precise control over wrinkles, crepey skin, delicate facial and body skin, and dermatological conditions like fibromas, skin tags, and xanthelasma.

January 2024: The medical aesthetics platform Empower Aesthetics has announced a collaboration with AW Skin Co. and DermaTouch RN.

January 2022: Galderma has completed its acquisition of ALASTIN Skincare®, Inc. and has obtained antitrust approval from US regulators.

January 2021: Candela introduced the Frax Pro system, the first FDA-approved non-ablative fractional device to resurface dual-depth skin. It features the Frax 1940 and Frax 1550 applicators.

Procedure- Market breakup in 3 viewpoints:

1. Injectables
2. Skin Rejuvenation
3. Others

Injectables- Market breakup in 4 viewpoints:

1. Botulinum Toxin
2. Hyaluronic Acid
3. Calcium Hydroxylapatite
4. Poly-L-Lactic Acid

Skin Rejuvenation- Market breakup in 4 viewpoints:

1. Photo Rejuvenation
2. Chemical peel
3. Micro Ablative Resurfacing
4. Full field Ablative

Others- Market breakup in 2 viewpoints:

1. Hair Removal
2. Non Surgical Fat Reduction

Gender- Market breakup in 2 viewpoints:

1. Male
2. Female

End User- Market breakup in 2 viewpoints:

1. Hospital/surgery centre
2. Medspa
3. Traditional Spa
4. HCP Owned Clinic

Country - Market breakup of 17 Countries:

1. United States
2. Brazil
3. Japan
4. Mexico
5. Turkey
6. Germany
7. Argentina
8. Italy
9. Colombia
10. India
11. Spain
12. Greece
13. Iran
14. Romania
15. United Kingdom
16. Thailand
17. Rest of the world

All the key players have been covered from 4 Viewpoints:

  • Business Overview
  • Product Portfolio
  • Recent Development
  • Revenue Analysis

Key Players Analysis:

1. Johnson & Johnson
2. Bausch Health Companies Inc.
3. Cutera Inc.
4. AbbVie Inc.
5. Sisram Medical Ltd.
6. Galderma S.A
7. Sientra Inc.
8. Revance Therapeutics Inc.

Table of Contents

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenge
5. Non-Invasive Aesthetic Treatment Market
6. Market Share
6.1 By Procedure
6.2 By Gender
6.3 By End User
6.4 By Countries
7. Procedure
7.1 Injectables
7.1.1 Botulinum Toxin
7.1.2 Hyaluronic Acid
7.1.3 Calcium Hydroxylapatite
7.1.4 Poly-L-Lactic Acid
7.2 Facial Rejuvenation
7.2.1 Photo Rejuvenation
7.2.2 Chemical peel
7.2.3 Micro Ablative Resurfacing
7.2.4 Full field Ablative
7.3 Others
7.3.1 Hair Removal
7.3.2 Non Surgical Fat Reduction
8. Gender
8.1 Male
8.2 Female
9. End User
9.1 Hospital/surgery centre
9.2 Medspa
9.3 Traditional Spa
9.4 HCP Owned Clinic
10. Countries
10.1 United States
10.2 Brazil
10.3 Japan
10.4 Mexico
10.5 Turkey
10.6 Germany
10.7 Argentina
10.8 Italy
10.9 Colombia
10.10 India
10.11 Spain
10.12 Greece
10.13 Iran
10.14 Romania
10.15 United Kingdom
10.16 Thailand
10.17 Rest of the world
11. Porter’s Five Forces Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes
12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat
13. Key Players Analysis
13.1 Johnson & Johnson
13.1.1 Business Overview
13.1.2 Key Persons
13.1.3 Product Portfolio
13.1.4 Recent Development
13.1.5 Sales Analysis
13.2 Bausch Health Companies Inc.
13.2.1 Business Overview
13.2.2 Key Persons
13.2.3 Product Portfolio
13.2.4 Recent Development
13.2.5 Sales Analysis
13.3 Cutera Inc.
13.3.1 Business Overview
13.3.2 Key Persons
13.3.3 Product Portfolio
13.3.4 Recent Development
13.3.5 Sales Analysis
13.4 AbbVie Inc.
13.4.1 Business Overview
13.4.2 Key Persons
13.4.3 Product Portfolio
13.4.4 Recent Development
13.4.5 Sales Analysis
13.5 Sisram Medical Ltd.
13.5.1 Business Overview
13.5.2 Key Persons
13.5.3 Product Portfolio
13.5.4 Recent Development
13.5.5 Sales Analysis
13.6 Galderma S.A
13.6.1 Business Overview
13.6.2 Key Persons
13.6.3 Product Portfolio
13.6.4 Recent Development
13.6.5 Sales Analysis
13.7 Sientra Inc.
13.7.1 Business Overview
13.7.2 Key Persons
13.7.3 Product Portfolio
13.7.4 Recent Development
13.7.5 Sales Analysis
13.8 Revance Therapeutics Inc.
13.8.1 Business Overview
13.8.2 Key Persons
13.8.3 Product Portfolio
13.8.4 Recent Development
13.8.5 Sales Analysis

Companies Mentioned

  • Johnson & Johnson
  • Bausch Health Companies Inc.
  • Cutera Inc.
  • AbbVie Inc.
  • Sisram Medical Ltd.
  • Galderma S.A
  • Sientra Inc.
  • Revance Therapeutics Inc.

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information